The overnight dexamethasone suppression test: clinical and theoretical review.
The overnight dexamethasone suppression test (DST) has emerged as a useful clinical test in identifying a proportion of patients with primary affective disorder. This test may also be helpful in predicting response to tricyclic antidepressants, MAO inhibitors, and/or electroconvulsive therapy. This review summarized the recent clinical studies on the DST.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D003866:Depressive Disorder / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D003907:Dexamethasone; D003937:Diagnosis, Differential; D004565:Electroconvulsive Therapy; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D001523:Mental Disorders / Q000097:blood / Q000175:diagnosis; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D003907:Dexamethasone; D006854:Hydrocortisone